Form 8-K - Current report:
SEC Accession No. 0001193125-25-173626
Filing Date
2025-08-05
Accepted
2025-08-05 17:15:17
Documents
13
Period of Report
2025-08-02
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d88091d8k.htm   iXBRL 8-K 31144
2 EX-16.1 d88091dex161.htm EX-16.1 1644
  Complete submission text file 0001193125-25-173626.txt   152824

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ima-20250802.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ima-20250802_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ima-20250802_pre.xml EX-101.PRE 11718
16 EXTRACTED XBRL INSTANCE DOCUMENT d88091d8k_htm.xml XML 3831
Mailing Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130
Business Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130 857-343-8292
ImageneBio, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 811697316 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 251186177
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)